Drug intelligence / Profile preview

immune globulin

Development stage
Approved
Lead developer
ADMA Biologics
Modality
Recombinant Proteins and Enzymes
Administration
Intravenous, Subcutaneous, Intramuscular
01

Overview

Immune globulin is a blood product derived from human plasma containing antibodies that help strengthen the immune system. It consists of pooled IgG antibodies from healthy donors and contains the same distribution of IgG subclasses found in normal human plasma (approximately 70.3% IgG1, 24.7% IgG2, 3.1% IgG3, and 1.9% IgG4). The mechanism of action is multifactorial, involving both Fc-dependent and F(ab')2-dependent effects. Immune globulin works by blocking Fc receptors on immune cells, neutralizing autoantibodies, modulating cytokine production, preventing complement-mediated tissue damage, and regulating T and B cell functions. It is primarily used to treat primary immunodeficiency disorders, autoimmune conditions, and inflammatory diseases.

Brand names
Gammagard S/DCarimune NFCarimuneBivigamFlebogammaGammagardGammaplexGamunex-COctagamPrivigenFlebogamma 10% DIFFlebogamma 5% DIFGammakedPanzygaAscenivAlygloBaygamCutaquigCuvitruGamaSTANGamastan S/DGamimune NGammaplex 10%Gammar-PGamunexHizentraIveegam ENOctagam 10%Panglobulin NFPolygam S/DSandoglobulinVenoglobulin-SVivaglobinXembifyYimmugo
Other names
Human immunoglobulin GIntravenous immunoglobulinHuman Rho(D) immune globulin
02

Targets

C1Q (Complement C1q)FcγR (Low affinity immunoglobulin gamma Fc region receptor II-c)FCGRT (Neonatal crystallizable fragment receptor)

Beyond the preview

Go deeper on immune globulin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on immune globulin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call